Accessibility Menu
 
Tango Therapeutics logo

Tango Therapeutics

(NASDAQ) TNGX

Current Price$25.12
Market Cap$3.76B
Since IPO (2020)+157%
5 Year+128%
1 Year+1,703%
1 Month+37%

Tango Therapeutics Financials at a Glance

Market Cap

$3.76B

Revenue (TTM)

$62.38M

Net Income (TTM)

$101.59M

EPS (TTM)

$-0.86

P/E Ratio

-30.46

Dividend

$0.00

Beta (Volatility)

1.22 (Average)

Price

$25.12

Volume

77,313

Open

$25.74

Previous Close

$25.12

Daily Range

$24.32 - $26.36

52-Week Range

$1.03 - $28.41

About Tango Therapeutics

Industry

Biotechnology

Employees

137

CEO

Barbara L. Weber, MD

Headquarters

Boston, MA 02142, US

TNGX Financials

Key Financial Metrics (TTM)

Gross Margin

97%

Operating Margin

-2%

Net Income Margin

-2%

Return on Equity

-37%

Return on Capital

-30%

Return on Assets

-25%

Earnings Yield

-3.28%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.76B

Shares Outstanding

142.69M

Volume

77.31K

Avg. Volume

3.26M

Financials (TTM)

Gross Profit

$60.10M

Operating Income

$111.29M

EBITDA

$109.01M

Operating Cash Flow

$138.89M

Capital Expenditure

$1.05M

Free Cash Flow

$139.93M

Cash & ST Invst.

$343.14M

Total Debt

$33.57M

Tango Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$479.00K

-111.6%

Gross Margin

0.00%

N/A

Market Cap

$3.76B

N/A

Market Cap/Employee

$24.24M

N/A

Employees

155

N/A

Net Income

$38.75M

-2.9%

EBITDA

$41.38M

-2.7%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$309.57M

+39.8%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$30.83M

-9.4%

Short Term Debt

$2.74M

+11.6%

Return on Assets

-25.48%

N/A

Return on Invested Capital

-29.52%

N/A

Free Cash Flow

$29.94M

+18.6%

Operating Cash Flow

$29.72M

+18.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
KODKodiak Sciences Inc.
$45.43+2.99%
NRIXNurix Therapeutics, Inc.
$17.08+3.58%
BCAXBicara Therapeutics Inc. Common Stock
$21.92-2.47%
URGNUroGen Pharma Ltd.
$24.12+1.47%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$84.52-0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$60.74-0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.14-0.01%
SOFISoFi Technologies
$18.36-0.02%

Questions About TNGX

What is the current price of Tango Therapeutics?

Tango Therapeutics is trading at $25.12 per share.

What is the 52-week range for Tango Therapeutics?

Over the past 52 weeks, Tango Therapeutics has traded between $1.03 and $28.41.

How much debt does Tango Therapeutics have?

As of the most recent reporting period, Tango Therapeutics reported total debt of $33.57M.

How much cash does Tango Therapeutics have on hand?

Tango Therapeutics reported $112.71M in cash and cash equivalents in its most recent financial results.

What is Tango Therapeutics’s dividend yield?

Tango Therapeutics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.